Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse

OBJECTIVE: Previous studies showed that genetic deletion or pharmacological blockade of the receptor for advanced glycation end products (RAGE) prevents the early structural changes in the glomerulus associated with diabetic nephropathy. To overcome limitations of mouse models that lack the progress...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Reiniger, Nina, Lau, Kai, McCalla, Daren, Eby, Bonnie, Cheng, Bin, Lu, Yan, Qu, Wu, Quadri, Nosirudeen, Ananthakrishnan, Radha, Furmansky, Maryana, Rosario, Rosa, Song, Fei, Rai, Vivek, Weinberg, Alan, Friedman, Richard, Ramasamy, Ravichandran, D'Agati, Vivette, Schmidt, Ann Marie
פורמט: Artigo
שפה:Inglês
יצא לאור: American Diabetes Association 2010
נושאים:
Complications
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2911065/
https://ncbi.nlm.nih.gov/pubmed/20627935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db09-1766
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים